FRMM - 180 Life Sciences Corp.
3
-0.290 -9.667%
Share volume: 386,156
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$3.29
-0.29
-0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-14-2024 | 05-15-2025 | 07-23-2025 | 11-14-2025 | |
| Cash flow financing | -264.394 K | -264.908 K | -476.065 K | -3.320 K | -350.000 K | 825.476 M | |
| Other financing cash flows | 489.000 | -489.000 | 489.000 | 0.000 | 0.000 | 5.680 M | |
| Cash flow | -1.298 M | 0.000 | 0.000 | -857.043 K | 0.000 | 556.672 M | |
| Net income | -1.070 M | 11.781 K | -836.720 K | -2.369 M | -1.727 M | -216.742 M | |
| Depreciation | 0.000 | 0.000 | 13.851 K | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -252.370 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -1.298 M | 468.300 K | -511.493 K | -860.614 K | -1.506 M | 556.701 M |